Unclaimed Scholar Profile
Are you Takamasa Ueno? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at Muhimbili University of Health and Allied SciencesASIDASID-9186-7607-1926 orcid.org/0000-0003-4852-4236
Takamasa Ueno
Muhimbili University of Health and Allied Sciences
Faculty researcher at Muhimbili University of Health and Allied Sciences (TZ), specializing in Physical Sciences & Engineering. [Discipline: Physical Sciences & Engineering] [Scholar Type: Policy & Economics Specialist] [Career Tier: Distinguished Scholar] [Region: East Africa]
#HIV Research and Treatment#SARS-CoV-2 and COVID-19 Research#HIV/AIDS drug development and treatment#vaccines and immunoinformatics approaches
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 7,678 | 3,685 |
| h-index | 36 | 27 |
| i10-index | 92 | 64 |
Annual Citation Growth
Verified Citations / Year0
2020369
2021+40%516
2022+28%663
2023+33%884
2024-8%811
2025-45%442
2026Scholarship Distribution & Proportions164 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:25% African Regional Citations (1,920) • 75% Global Research Impact (5,758)
164 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (164)
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Published in Nature•2022
DOI: 10.1038/s41586-022-04474-x Verified Peer-Reviewed
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
Published in Nature•2022
DOI: 10.1038/s41586-022-04462-1 Verified Peer-Reviewed
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Published in Cell Host & Microbe•2021
DOI: 10.1016/j.chom.2021.06.006 Verified Peer-Reviewed
SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity
Published in Nature Communications•2021
DOI: 10.1038/s41467-021-21118-2 Verified Peer-Reviewed
Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides.
Published in Proceedings of the National Academy of Sciences•1995
DOI: 10.1073/pnas.92.6.2398 Verified Peer-Reviewed
Showing 1 – 5 of 164 publications
1 / 33